Additional information
White Powder
57171-18-3
ACI-045016
234.5-235.4°C
C24H30O6
414.49
Ambient
2-8°C
Anti-inflammatory
Pharmaceutical Impurity Standards
(11?,16?)-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-3,20-dioxo-Pregna-1,4-dien-21-al
(11ß,?16a)?-11-?hydroxy-?16,?17-?[(1-?methylethylidene)?bis(oxy)?]?-?3,?20-?dioxo- Pregna-?1,?4-?dien-?21-?al (Desonide glyoxal)
Desonide-21-aldehyde





![N-METHYL ENZALUTAMIDE (25 mg) (4-{3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl}-2-fluoro-N,N-dimethylbenzamide)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)